MXPA05001275A - 2-amino-benzotiazolsulfonhamida como inhibidores de proteasa de virus de inmunodeficiencia humana de amplio espectro. - Google Patents
2-amino-benzotiazolsulfonhamida como inhibidores de proteasa de virus de inmunodeficiencia humana de amplio espectro.Info
- Publication number
- MXPA05001275A MXPA05001275A MXPA05001275A MXPA05001275A MXPA05001275A MX PA05001275 A MXPA05001275 A MX PA05001275A MX PA05001275 A MXPA05001275 A MX PA05001275A MX PA05001275 A MXPA05001275 A MX PA05001275A MX PA05001275 A MXPA05001275 A MX PA05001275A
- Authority
- MX
- Mexico
- Prior art keywords
- amino
- hiv protease
- 6alkyl
- hydrogen
- broadspectrum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invencion se refiere al uso de 2-amino-benzotiazoles, que tienen la formula en donde R1 es hexahidrofuro[2,3-b]furanilo, tetrahidrofuranilo, oxazolilo, tiazolilo, piridinilo o fenilo opcionalmente sustituido con uno o mas sustituyentes independientemente seleccionados de alquilo de C1-6, hidroxi, amino, halogeno, amino-alquilo de C1-4 y mono-o di(alquilo de C1-4)amino; R2 es hidrogeno o alquilo de C1-6 L es un enlace directo, -O-, alcanodiilo de C1-6-O- o -0-alcanodiilo de C1-6 R3 es fenilo-alquilo de C1-4 R4 es alquilo de C1-6 R5 es hidrogeno o alquilo de C1-6 R6 es hidrogeno o alquilo de C1-6 en la fabricacion de un medicamento util para inhibir proteasa de VIH mutante en un mamifero infectado con proteasa de VIH mutante; tambien se refiere a compuestos novedosos de la formula (1).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02078231 | 2002-08-02 | ||
| US42786202P | 2002-11-20 | 2002-11-20 | |
| PCT/EP2003/050359 WO2004014371A1 (en) | 2002-08-02 | 2003-08-04 | Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05001275A true MXPA05001275A (es) | 2005-04-28 |
Family
ID=31716850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05001275A MXPA05001275A (es) | 2002-08-02 | 2003-08-04 | 2-amino-benzotiazolsulfonhamida como inhibidores de proteasa de virus de inmunodeficiencia humana de amplio espectro. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050267156A1 (es) |
| EP (1) | EP1545518A1 (es) |
| KR (1) | KR20050025647A (es) |
| CN (1) | CN1671380B (es) |
| AP (1) | AP1878A (es) |
| AU (1) | AU2003262561B2 (es) |
| BR (1) | BR0305717A (es) |
| CA (1) | CA2492832C (es) |
| EA (1) | EA008594B1 (es) |
| HR (1) | HRP20050605A2 (es) |
| IL (1) | IL166257A (es) |
| MX (1) | MXPA05001275A (es) |
| NO (1) | NO20051089L (es) |
| NZ (1) | NZ538488A (es) |
| PL (1) | PL374948A1 (es) |
| WO (1) | WO2004014371A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2566340C (en) * | 2004-05-07 | 2014-05-06 | Sequoia Pharmaceuticals, Inc. | Resistance-repellent retroviral protease inhibitors |
| JO2841B1 (en) * | 2006-06-23 | 2014-09-15 | تيبوتيك فارماسيوتيكالز ليمتد | 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV) |
| US8267163B2 (en) * | 2008-03-17 | 2012-09-18 | Visteon Global Technologies, Inc. | Radiator tube dimple pattern |
| WO2011061590A1 (en) | 2009-11-17 | 2011-05-26 | Hetero Research Foundation | Novel carboxamide derivatives as hiv inhibitors |
| CA2802492C (en) | 2010-07-02 | 2018-10-16 | Gilead Sciences, Inc. | 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| ES2634490T3 (es) | 2010-07-02 | 2017-09-28 | Gilead Sciences, Inc. | Derivados de ácido napht-2-ylacetico para tratar el sida |
| US9024038B2 (en) | 2010-12-27 | 2015-05-05 | Purdue Research Foundation | Compunds and methods for treating HIV |
| AP2013007249A0 (en) | 2011-04-21 | 2013-11-30 | Gilead Sciences Inc | Benzothiazole compounds and their pharmaceutical use |
| WO2013103724A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
| WO2013103738A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | Napthalene acetic acid derivatives against hiv infection |
| PH12014500842A1 (en) | 2012-04-20 | 2014-06-09 | Gilead Sciences Inc | Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| DE69415326T2 (de) * | 1993-08-24 | 1999-06-02 | G.D. Searle & Co., Chicago, Ill. | Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen |
| AU4828199A (en) * | 1998-06-23 | 2000-01-10 | Board Of Trustees Of The University Of Illinois, The | Multi-drug resistant retroviral protease inhibitors and associated methods |
| NZ527391A (en) * | 2001-02-14 | 2005-04-29 | Tibotec Pharm Ltd | Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
-
2003
- 2003-08-04 NZ NZ538488A patent/NZ538488A/en not_active IP Right Cessation
- 2003-08-04 KR KR1020057001206A patent/KR20050025647A/ko not_active Ceased
- 2003-08-04 PL PL03374948A patent/PL374948A1/xx not_active Application Discontinuation
- 2003-08-04 AU AU2003262561A patent/AU2003262561B2/en not_active Ceased
- 2003-08-04 CA CA2492832A patent/CA2492832C/en not_active Expired - Fee Related
- 2003-08-04 CN CN038184044A patent/CN1671380B/zh not_active Expired - Fee Related
- 2003-08-04 US US10/523,445 patent/US20050267156A1/en not_active Abandoned
- 2003-08-04 EP EP03784205A patent/EP1545518A1/en not_active Ceased
- 2003-08-04 HR HR20050605A patent/HRP20050605A2/hr not_active Application Discontinuation
- 2003-08-04 AP AP2005003242A patent/AP1878A/xx active
- 2003-08-04 EA EA200500298A patent/EA008594B1/ru not_active IP Right Cessation
- 2003-08-04 WO PCT/EP2003/050359 patent/WO2004014371A1/en not_active Ceased
- 2003-08-04 MX MXPA05001275A patent/MXPA05001275A/es active IP Right Grant
- 2003-08-04 BR BR0305717-8A patent/BR0305717A/pt not_active Application Discontinuation
-
2005
- 2005-01-12 IL IL166257A patent/IL166257A/en not_active IP Right Cessation
- 2005-03-01 NO NO20051089A patent/NO20051089L/no not_active Application Discontinuation
-
2009
- 2009-04-20 US US12/426,730 patent/US20090203742A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR0305717A (pt) | 2004-09-28 |
| KR20050025647A (ko) | 2005-03-14 |
| CN1671380B (zh) | 2010-05-26 |
| EA200500298A1 (ru) | 2005-08-25 |
| WO2004014371A1 (en) | 2004-02-19 |
| US20090203742A1 (en) | 2009-08-13 |
| CN1671380A (zh) | 2005-09-21 |
| CA2492832C (en) | 2012-05-22 |
| AP2005003242A0 (en) | 2005-03-31 |
| US20050267156A1 (en) | 2005-12-01 |
| NZ538488A (en) | 2007-10-26 |
| EA008594B1 (ru) | 2007-06-29 |
| AP1878A (en) | 2008-08-13 |
| EP1545518A1 (en) | 2005-06-29 |
| HRP20050605A2 (en) | 2006-02-28 |
| AU2003262561B2 (en) | 2008-10-16 |
| NO20051089L (no) | 2005-05-02 |
| IL166257A0 (en) | 2006-01-15 |
| PL374948A1 (en) | 2005-11-14 |
| AU2003262561A1 (en) | 2004-02-25 |
| IL166257A (en) | 2013-04-30 |
| CA2492832A1 (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| MXPA04004037A (es) | Compuestos novedosos de 1, 2, 4-de triazol. | |
| DE60336850D1 (en) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| BR0210030A (pt) | Derivado de fenilpiridinacarbonilpiperazina | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| PL366590A1 (en) | Novel compounds as anti-inflammatorz, immunomodulatory and anti-proliferatory agents | |
| GB0305142D0 (en) | Synthesis | |
| DK1613304T3 (da) | DPP-IV-inhibitorer | |
| MY136789A (en) | Metalloproteinase inhibitors | |
| SE0201976D0 (sv) | Novel compounds | |
| TW200730540A (en) | Novel peptide compounds | |
| WO2005028429A3 (en) | Haloalkyl containing compounds as cysteine protease inhibitors | |
| MY129188A (en) | Metalloproteinase inhibitors | |
| MXPA05001275A (es) | 2-amino-benzotiazolsulfonhamida como inhibidores de proteasa de virus de inmunodeficiencia humana de amplio espectro. | |
| EP1709037B8 (en) | Hiv protease inhibiting sulfonamides | |
| TW200626564A (en) | Carboxylic acid derivative containing thiazole ring and medical use thereof | |
| IL190024A0 (en) | Stabilized protease composition | |
| NO20063944L (no) | Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister | |
| TW200505446A (en) | Inhibitor of cox | |
| ATE526323T1 (de) | Die hiv-protease hemmende verbindungen | |
| IL189286A0 (en) | Novel cysteine protease inhibitors and their therapeutic applications | |
| TW200606163A (en) | Imidazopyridine compound | |
| MXPA04003478A (es) | Sintesis de (4-bromofenil)(4-piperidil)metanona-(z)-o-etiloxima y sales. | |
| WO2006095139A3 (en) | Cancer treatment using specific 3,6,9-substituted acridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |